England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...

TOKYO — China has agreed on procedures to resume imports of Japanese seafood products, Japan's government said on Friday, marking a step toward ending a nearly two-year trade ban. Officials from Japan ...

China will resume seafood imports from Japan that it banned in 2023 over worries about the discharge of treated radioactive wastewater from the damaged Fukushima Daiichi nuclear power plant into ...

Lilly announced a definitive agreement to acquire private biotech, SiteOne Therapeutics, which will add novel non-opioid medicines for pain management to its pipeline portfolio. SiteOne Therapeutics ...

FILE - Japan's Princess Mako and her fiance Kei Komuro look at each other during a press conference at Akasaka East Residence in Tokyo, on Sept. 3, 2017. (AP Photo/Shizuo Kambayashi, Pool ...

A final decision from the FDA is expected on July 23, 2025. Blenrep combinations were approved in the United Kingdom and Japan in April and May 2025, respectively. Besides the United States and ...

Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending approval for the Blenrep (belantamab mafodotin) combination therapy to treat relapsed or refractory ...

This latest announcement follows the recent approvals of Blenrep combos by regulatory agencies in Japan and the UK. The pivotal Phase III trials, DREAMM-7 and DREAMM-8, have demonstrated superior ...

The CHMP opinion follows the approval of Blenrep combinations by the UK Medicines and Healthcare products Regulatory Agency (MHRA) in April and Japan’s Ministry of Health, Labour and Welfare earlier ...